FDA Inspection 1258048 — Boehringer Ingelheim RCV GmbH & Co KG

Boehringer Ingelheim RCV GmbH & Co KG — FEI 3003433722

The FDA completed an inspection of Boehringer Ingelheim RCV GmbH & Co KG on November 12, 2024 in Vienna. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 12, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Vienna (Austria)